Table 3.
Target therapy related with metabolite sensing in cancers
Category | Effect target | Targeted medicine | Targeted effect | Ref./refs. |
---|---|---|---|---|
Glucose | GLUT | Phloretin | Inhibitor | 86 |
Fasentin | 86 | |||
STF-31 | 86 | |||
WZB117 | 86 | |||
Ritonavir | 86 | |||
Silybin | 87 | |||
HK | 2-DG | Inhibitor | 88,89 | |
LN | Inhibitor | 90 | ||
Resveratrol | Inhibitor | 91 | ||
Astragalin | Antagonist | 92 | ||
Chrysin | Antagonist | 93 | ||
Genistein-27 | Antagonist | 94 | ||
Benserazide | Inhibitor | 95 | ||
PI3K/Akt | Afuresertib | Inhibitor | 96 | |
Uprosertib | ||||
Ipatasertib | ||||
mTORC1/2 | PP242 | Inhibitor | 101 | |
PI3K/mTOR | NVP-BEZ235 | Inhibitor | 102 | |
Fatty acid | GPR109A | MK1903 | Antagonist | 141 |
Acifran | 142 | |||
5-ANA | 143 | |||
GSK256073 | 144 | |||
Fatty acid β oxidation | Etomuslim | Antagonist | 136 | |
Peroxicillin | ||||
LDHA | FX11 | Inhibitor | 150,152 | |
N-hydroxy-2-carboxy-substituted indole compounds |
150,153 | |||
GPR43 | 4-CMTB | Agonist | 167–170 | |
AZ1729 | 167–170 | |||
GPR84 | Compound 33 | Antagonist | 174 | |
GLPG1205 | 175 | |||
LY-237 | Agonist | 178 | ||
6-Octylaminouracil | 179 | |||
GPR40 | GW100 | Antagonist | 184 | |
DC260126 | 185 | |||
GPR120 | AH7614 | Antagonist | 187,188 | |
GW9508 | Agonist | 190 | ||
TUG-891 | 192 | |||
Compound 39 | 193 | |||
GPR78 | Anti-CTD GPR78 antibody | Blocker | 197 | |
miR-936 | Antagonist | 198 | ||
HDAC | Vorinostat | Inhibitor | 223–225 | |
Entinostat | 226 | |||
Valproate | 227 | |||
Romidepsin | 228 | |||
CD44 | CD44 mono-antibody | Blocker | 256 | |
15-PGDH | HDAC inhibitors | Agonist | 269 | |
Nonsteroidal anti-inflammatory drugs | ||||
PPAR-γ agonists | ||||
FASN | Cerulenin | Inhibitor | 278 | |
ACSS2 | MTB-9655 | Inhibitor | NCT04990739 | |
ACC1 | TOFA | Inhibitor | 285 | |
ND-646 | 286,287 | |||
Amino acid | mTOR | Temsirolimus | Inhibitor | 322 |
eEF-2K | 323 | |||
GPR109A | Niacin | Agonist | 324 | |
GPR56 | Transglutaminase 2 | Inhibitor | 332 | |
LGR5 | Agonist | 340 | ||
Glutamine | ASCT2 | Agonist | 355 | |
v-9302 | Inhibitor | 356 | ||
Leucine | circFBXL5 | Agonist | 374 | |
mTORC1 | EP300 | Agonist | 378 | |
BCAT | BCAA | Agonist | 382,383 | |
Serine | PKM2 | Agonist | 388 |